2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

How Are Key Drivers Contributing to the Growth and Expansion of the Genetic Toxicology Testing Market?

The growth of the genetic toxicology testing market is anticipated to be driven by the escalating demand for personalized medicine. Personalized medicine, a healthcare model customizing decisions, practices, interventions, and products per individual patient based on their anticipated response or ailment risk, has seen a surge due to genetic advancements, enhanced comprehension of diseases, the accessibility of biomarker-grounded diagnostics, value-focused healthcare programs, and their amalgamation into clinical practice and study. Genetic toxicology testing plays a crucial role in personalized medicine by offering necessary data on genetic variability, response to treatment, and vulnerability to genotoxic agents. For example, the Personalized Medicine Coalition, a non-profit organization based in the US, reported in February 2024, that in 2023, the FDA approved 16 new personalized medicines for patients with rare diseases, up from six in 2022. Thus, the growing demand for personalized medicine is catalyzing the genetic toxicology testing market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15574&type=smp

#What Are the Key Projections for the CAGR of the Genetic Toxicology Testing Market From 2025 to 2034?

The size of the genetic toxicology testing market has seen swift expansion in the past few years. The market value will elevate from $1.63 billion in 2024 to hit $1.8 billion in 2025, with a compound annual growth rate (CAGR) of 10.4%. Factors such as escalating public health emergencies, proliferating globalization, a heightened emphasis on personalized healthcare, growing demand for thorough testing solutions, and an increase in drug numbers are responsible for the growth observed in the historic period.

Forecasted expansion of the genetic toxicology testing market is predicted to accelerate noticeably in the forthcoming years, with projections estimating a boom to $2.64 billion in 2029, boasting a compound annual growth rate (CAGR) of 10.0%. The projected growth in this upcoming period is mainly credited to the burgeoning demand for testing innovative foods, the escalating anxiety surrounding potential hazards, an increase in environmental and health concerns as well as growing regulatory oversight. Further impacting this market’s growth is the rising prominence of in vitro testing practices and the emergence of high-throughput screening frameworks. Notable emerging trends for the forecasted period encompass innovations in precision medicine and toxicogenomics, all-inclusive risk dialogue, methodologies in genetic toxicology testing, the evolution of risk assessment methodologies, the amalgamation of omics technologies and the progress in genomics and molecular biology.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15574

What New Market Trends Are Reshaping theGenetic Toxicology Testing Market and Its Opportunities?

Leading firms in the genetic toxicology testing industry are focusing on the creation of innovative drug screening platforms such as phenotypic drug screening, which enhances precision and effectiveness in pinpointing potential genetic toxins. Phenotypic drug screening is a methodology utilized in drug discovery that tests compounds based on their capability to elicit a particular cellular or physiological reaction in an entire organism or relevant cell system. For illustration, Creative Biogene, an American biotech firm, debuted zebrafish disease models in August 2022 to bolster drug discovery and toxicology studies. These models simulate human genetic diseases in zebrafish, yielding insights into disease pathogenesis, drug discovery, and toxicology. Creative Biogene’s zebrafish models present a critical platform for gauging drug toxicity, predicting the safety of novel compounds, and aiding the drug development procedure.

Who Are the Leading Market Players Fueling Growth in the Genetic Toxicology Testing Market Trend?

Major companies operating in the genetic toxicology testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, SGS SA, WuXi AppTec, Intertek Group plc, Charles River Laboratories International Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Fraunhofer ITEM, Jubilant Life Sciences Limited, Evotec SE, Inotiv Inc., Promega Corporation, Syngene International Limited, Nelson Laboratories LLC, Instem, Frontage Laboratories Inc., Creative Bioarray, Creative Biolabs Inc., Gentronix Limited, MB Research Laboratories

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/genetic-toxicology-testing-global-market-report

How is the Global Genetic Toxicology Testing Market Segemented?

The genetic toxicology testing market covered in this report is segmented –

1) By Type: In Vitro, In Vivo

2) By Product: Services, Reagents And Consumables, Assays

3) By Application: Healthcare Industry, Food Industry, Cosmetics Industry, Agriculture Industry, Other Applications

Subsegments:

1) By In Vitro: Ames Test, Micronucleus Assay, Comet Assay, Chromosomal Aberration Test, Cell Transformation Assay, Other In Vitro Methods

2) By In Vivo: Micronucleus Test (Rodent), Comet Assay (In Vivo), Bone Marrow Chromosomal Aberration Test, Dominant Lethal Test (Rodent), Other In Vivo Methods

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=15574&type=smp

Which Geographics are Influencing the Growth of the Genetic Toxicology Testing Market?

North America was the largest region in the genetic toxicology testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genetic toxicology testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Genetic Toxicology Testing Market 2025, By The Business Research Company:

ADME Toxicology Testing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/adme-toxicology-testing-global-market-report

Genetic Testing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/genetic-testing-global-market-report

Genetically Modified Crops Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/genetically-modified-crops-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: